The chemical substance known as "(8S,15S)-dihydroxy-(5Z,9E,11Z,13E)-eicosatetraen" with the CAS number 80234-65-7 is a polyunsaturated fatty acid derivative characterized by its specific stereochemistry and multiple double bonds. This compound features hydroxyl groups at the 8th and 15th carbon positions, contributing to its reactivity and potential biological activity. The presence of four double bonds in the eicosatetraen backbone indicates that it is a highly unsaturated fatty acid, which can influence its physical properties, such as melting point and solubility. The configuration of the double bonds (5Z, 9E, 11Z, 13E) suggests that it has both cis and trans configurations, which can affect its interaction with biological membranes and enzymes. Such compounds are often studied for their roles in cellular signaling, inflammation, and as precursors to bioactive lipids. Overall, this substance is of interest in biochemistry and pharmacology due to its potential health implications and applications in various fields.

(8S,15S)-dihydroxy-(5Z,9E,11Z,13E)-*eicosatetraen

80234-65-7: The chemical substance known as "(8S,15S)-dihydroxy-(5Z,9E,11Z,13E)-eicosatetraen" with the CAS number 80234-65-7 is a polyunsaturated fatty acid derivative characterized by its specific stereochemistry and multiple double bonds. This compound features hydroxyl groups at the 8th and 15th carbon positions, contributing to its reactivity and potential biological activity. The presence of four double bonds in the eicosatetraen backbone indicates that it is a highly unsaturated fatty acid, which can influence its physical properties, such as melting point and solubility. The configuration of the double bonds (5Z, 9E, 11Z, 13E) suggests that it has both cis and trans configurations, which can affect its interaction with biological membranes and enzymes. Such compounds are often studied for their roles in cellular signaling, inflammation, and as precursors to bioactive lipids. Overall, this substance is of interest in biochemistry and pharmacology due to its potential health implications and applications in various fields.

8(S),15(S)-dihydroxy-5(Z),9(E),11(Z),13(E)-eicosatetraenoic acid

8(S),15(S)-DiHETE, from 15(S)-HETE's oxidation by 15-LO, triggers eosinophil movement at 1.5 μM; it counteracts pain and LTB4 effects.

CAS 80234-65-7

(8S,15S)-dihydroxy-(5Z,9E,11Z,13E)-*eicosatetraen

8(S),15(S)-dihydroxy-5(Z),9(E),11(Z),13(E)-eicosatetraenoic acid

Ref: 48-14-4096

8(S),15(S)-DiHETE

Ref: TM-T37156